| Dr Jae Yeon Jung, MD, PHD | |
|
3810 Springhurst Blvd Ste 200, Louisville, KY 40241 | |
| (502) 583-1749 | |
| (502) 329-8184 |
| Full Name | Dr Jae Yeon Jung |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 29 Years |
| Location | 3810 Springhurst Blvd Ste 200, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013946375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 49240 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Norton Hospitals Inc | 9830001528 | 104 |
News Archive
Huntington Medical Research Institutes, a leading biomedical research organization, has announced the appointment of Marie Csete, MD, PhD, its chief scientific officer, to her new role as president and chief scientist of HMRI.
The Healing Group, a Salt Lake City-based women's wellness center, today announced the launch of its Hey Mom! campaign, designed to raise awareness, offer support and reduce the stigma commonly associated with postpartum depression (PPD) and related disorders.
Based on current scientific literature, gastrostomy tube (G-tube) placement or other long-term enteral access devices should be withheld or withdrawn in patients with advanced dementia or other near end-of-life conditions, according to a special report published today in the OnlineFirst version of Nutrition in Clinical Practice, the official journal of the American Society for Parenteral and Enteral Nutrition.
GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).
› Verified 7 days ago
| Entity Name | Norton Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073568879 PECOS PAC ID: 9830001528 Enrollment ID: O20031125000524 |
News Archive
Huntington Medical Research Institutes, a leading biomedical research organization, has announced the appointment of Marie Csete, MD, PhD, its chief scientific officer, to her new role as president and chief scientist of HMRI.
The Healing Group, a Salt Lake City-based women's wellness center, today announced the launch of its Hey Mom! campaign, designed to raise awareness, offer support and reduce the stigma commonly associated with postpartum depression (PPD) and related disorders.
Based on current scientific literature, gastrostomy tube (G-tube) placement or other long-term enteral access devices should be withheld or withdrawn in patients with advanced dementia or other near end-of-life conditions, according to a special report published today in the OnlineFirst version of Nutrition in Clinical Practice, the official journal of the American Society for Parenteral and Enteral Nutrition.
GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).
› Verified 7 days ago
| Entity Name | Associates In Dermatology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629083399 PECOS PAC ID: 1658263876 Enrollment ID: O20040325000047 |
News Archive
Huntington Medical Research Institutes, a leading biomedical research organization, has announced the appointment of Marie Csete, MD, PhD, its chief scientific officer, to her new role as president and chief scientist of HMRI.
The Healing Group, a Salt Lake City-based women's wellness center, today announced the launch of its Hey Mom! campaign, designed to raise awareness, offer support and reduce the stigma commonly associated with postpartum depression (PPD) and related disorders.
Based on current scientific literature, gastrostomy tube (G-tube) placement or other long-term enteral access devices should be withheld or withdrawn in patients with advanced dementia or other near end-of-life conditions, according to a special report published today in the OnlineFirst version of Nutrition in Clinical Practice, the official journal of the American Society for Parenteral and Enteral Nutrition.
GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jae Yeon Jung, MD, PHD Po Box 950132, Louisville, KY 40295-0132 Ph: (888) 980-8992 | Dr Jae Yeon Jung, MD, PHD 3810 Springhurst Blvd Ste 200, Louisville, KY 40241 Ph: (502) 583-1749 |
News Archive
Huntington Medical Research Institutes, a leading biomedical research organization, has announced the appointment of Marie Csete, MD, PhD, its chief scientific officer, to her new role as president and chief scientist of HMRI.
The Healing Group, a Salt Lake City-based women's wellness center, today announced the launch of its Hey Mom! campaign, designed to raise awareness, offer support and reduce the stigma commonly associated with postpartum depression (PPD) and related disorders.
Based on current scientific literature, gastrostomy tube (G-tube) placement or other long-term enteral access devices should be withheld or withdrawn in patients with advanced dementia or other near end-of-life conditions, according to a special report published today in the OnlineFirst version of Nutrition in Clinical Practice, the official journal of the American Society for Parenteral and Enteral Nutrition.
GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).
› Verified 7 days ago
Mrs. Jyoti B. Burruss, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 200, Louisville, KY 40241 Phone: 502-583-1749 Fax: 502-329-8184 | |
Vilma C Fabre, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2211 Greene Way, Ste 100, Louisville, KY 40220 Phone: 502-495-1162 Fax: 502-495-0156 | |
Elizabeth Veasey, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 800 Zorn Ave, Louisville, KY 40206 Phone: 502-287-4000 | |
Andrea S Burch, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2307 Greene Way Ste C, Louisville, KY 40220 Phone: 502-806-3376 Fax: 502-213-3999 | |
Dr. Steven J Hodge, MD Dermatology Medicare: Medicare Enrolled Practice Location: 310 E Broadway, Ste 200, Louisville, KY 40202 Phone: 502-585-5249 Fax: 502-585-5251 | |
Dr. Michael Mccall Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 200, Louisville, KY 40241 Phone: 502-322-1946 Fax: 502-329-8184 |